N-[6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1H-indole-3-carboxamide (SAR216471), a novel intravenous and oral, reversible, and directly acting P2Y12 antagonist.
about
N-[6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1H-indole-3-carboxamide (SAR216471), a novel intravenous and oral, reversible, and directly acting P2Y12 antagonist.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
N-[6-(4-butanoyl-5-methyl-1H-p ...... ectly acting P2Y12 antagonist.
@en
N-[6-(4-butanoyl-5-methyl-1H-p ...... ectly acting P2Y12 antagonist.
@nl
type
label
N-[6-(4-butanoyl-5-methyl-1H-p ...... ectly acting P2Y12 antagonist.
@en
N-[6-(4-butanoyl-5-methyl-1H-p ...... ectly acting P2Y12 antagonist.
@nl
prefLabel
N-[6-(4-butanoyl-5-methyl-1H-p ...... ectly acting P2Y12 antagonist.
@en
N-[6-(4-butanoyl-5-methyl-1H-p ...... ectly acting P2Y12 antagonist.
@nl
P2093
P356
P1476
N-[6-(4-butanoyl-5-methyl-1H-p ...... ectly acting P2Y12 antagonist.
@en
P2093
Alain Badorc
Angélina Besse
Anne-Marie Pflieger
Benjamin Gau
Christophe Boldron
Christophe Briot
Françoise Bono
Frédérique Dol
Gernot Zech
Gilbert Lassalle
P304
P356
10.1021/JM500588W
P407
P50
P577
2014-08-25T00:00:00Z